RMD News and Press, ResMed Inc. From 07/05/23

Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment Diagnostic management platform is upstream of and complementary to ResMed’s current post-testing AirView...

2023-07-04 14:57:41 ET Summary ResMed Inc., a leader in digital health and cloud-connected medical devices, is being considered as a potential addition to a healthcare portfolio due to its consistent financial performance and innovative product ecosystem. Despite a low yield and s...

2023-06-11 08:41:55 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...

The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, respectively A third study estimates over 200 million women have mild obstructive sleep apnea worldwide I...

2023-06-06 08:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023, beginning at approximately 9:20...

2023-06-04 12:00:08 ET Billions of dollars in sales across various MedTech markets will be at stake if there is a broader acceptance of weight loss drugs developed by Novo Nordisk ( NVO ) and Eli Lilly ( NYSE: LLY ), Morgan Stanley argued in a research note last week. Novo N...

France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSA Germany’s Michael Arzt presented new evidence that treating CSA with ASV* caused “...

2023-05-23 07:39:57 ET Goldman Sachs is more bullish on the U.S. economy than the rest of Wall Street. But its equity team has a list of stocks in case a hard landing from the tightening cycle materializes. Goldman's economists put the chance of a recession at 35%, compared with the Wal...

2023-05-10 02:10:00 ET Summary A punishing 2022 for Meta Platforms created a valuation opportunity - one that has paid off as it becomes the top contributor year-to-date for the Morningstar Wide Moat Focus Index. April was a subdued month - at least relative to the volatility seen...